Who Has Used Internal Company Documents for Biomedical and Public Health Research and Where Did They Find Them?

The ADVANTAGE Seeding Trial: A Review of Internal Documents

(2013) Kevin P. Hill et al.   ANNALS OF INTERNAL MEDICINE

A Historic Moment for Open Science: The Yale University Open Data Access Project and Medtronic

(2013) Harlan M. Krumholz et al.   ANNALS OF INTERNAL MEDICINE

Restoring invisible and abandoned trials: a call for people to publish the findings

(2013) P. Doshi et al.   BMJ-British Medical Journal

Differences in Reporting of Analyses in Internal Company Documents Versus Published Trial Reports: Comparisons in Industry-Sponsored Trials in Off-Label Uses of Gabapentin

(2013) S. Swaroop Vedula et al.   PLOS MEDICINE

The manufacture of lifestyle: The role of corporations in unhealthy living

(2012) Nicholas Freudenberg   JOURNAL OF PUBLIC HEALTH POLICY

Open Doorway to Truth: Legacy of the Minnesota Tobacco Trial

(2012) Richard D. Hurt et al.   MAYO CLINIC PROCEEDINGS

Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigation

(2012) S Swaroop Vedula et al.   Trials

The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience

(2012) Peter Doshi et al.   PLOS MEDICINE

Publication Bias in Antipsychotic Trials: An Analysis of Efficacy Comparing the Published Literature to the US Food and Drug Administration Database

(2012) Erick H. Turner et al.   PLOS MEDICINE

Conflicted Medical Journals and the Failure of Trust

(2011) Jon N. Jureidini et al.   Accountability in Research-Policies and Quality Assurance

Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO

(2011) Kay Dickersin et al.   JOURNAL OF THE ROYAL SOCIETY OF MEDICINE

Tobacco documents research methodology

(2011) S. J. Anderson et al.   TOBACCO CONTROL

Persistence of Cardiovascular Risk After Rofecoxib Discontinuation

(2010) Joseph S. Ross   ARCHIVES OF INTERNAL MEDICINE

The Haunting of Medical Journals: How Ghostwriting Sold “HRT”

(2010) Adriane J. Fugh-Berman   PLOS MEDICINE

Moral Disengagement in the Corporate World

(2009) Jenny White et al.   Accountability in Research-Policies and Quality Assurance

Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use

(2009) S. Swaroop Vedula et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Neurontin Legacy — Marketing through Misinformation and Manipulation

(2009) C. Seth Landefeld et al.   NEW ENGLAND JOURNAL OF MEDICINE

The promotion of olanzapine in primary care: An examination of internal industry documents

(2009) Glen I. Spielmans   SOCIAL SCIENCE & MEDICINE

Industry-Sponsored Ghostwriting in Clinical Trial Reporting: A Case Study

(2008) Leemon B. McHenry et al.   Accountability in Research-Policies and Quality Assurance

The Role of Corporate Credibility in Legitimizing Disease Promotion

(2008) Patricia A. McDaniel et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Guest Authorship and Ghostwriting in Publications Related to Rofecoxib

(2008) Joseph S. Ross et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Reporting Mortality Findings in Trials of Rofecoxib for Alzheimer Disease or Cognitive Impairment

(2008) Bruce M. Psaty et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation

(2008) Kristin Rising et al.   PLOS MEDICINE